🇩🇪 Germany Country × Condition
cancer Clinical Trials in Germany
Active clinical trials for cancer with research sites in Germany. All data sourced live from ClinicalTrials.gov — updated daily.
Active Trials: 5 // Recruiting: 5 Phases: Phase 1, Phase 1, Phase 2 // Updated: Daily
Total Trials
5
Recruiting Now
5
Country
🇩🇪 Germany
Active Trials in Germany (5)
NCT05359445 Phase 1
Recruiting
IMA401 TCER® in Recurrent and/or Refractory Solid Tumors, Alone or in Combination With a Checkpoint Inhibitor
Enrollment
95 pts
Country
🇩🇪 Germany
Immatics Biotechnologies GmbH
View Trial → NCT06809101
Recruiting
Home Monitoring of Complete Blood Count Performed by Patients - a Pilot Study on the Implementation Process in South Baltic Countries.
Enrollment
265 pts
Country
🇩🇪 Germany
Pomeranian Medical University Szcze...
View Trial → NCT03686124 Phase 1, Phase 2
Recruiting
ACTengine® IMA203/IMA203CD8 as Monotherapy or in Combination With Nivolumab in Recurrent and/or Refractory Solid Tumors
Enrollment
375 pts
Country
🇩🇪 Germany
Immatics US, Inc.
View Trial → NCT05336318
Recruiting
Peer2Me: A Peer Supported Program for Adolescent and Young Adult Cancer Patients
Enrollment
180 pts
Country
🇩🇪 Germany
University of Leipzig
View Trial → NCT06829290
Recruiting
Influence of Sarcopenia on the Course of the Diseases
Enrollment
200 pts
Country
🇩🇪 Germany
Universitatsmedizin Mainz - 1. Medi...
View Trial → Frequently Asked Questions
How many cancer clinical trials are active in Germany?
There are currently 5 active clinical trials for cancer with sites in Germany, of which 5 are actively recruiting patients.
How can I join a cancer clinical trial in Germany?
To join a cancer clinical trial in Germany, select a recruiting trial below and check the eligibility criteria. Contact the trial's principal investigator or the listed site in Germany directly. All trials listed here are sourced from ClinicalTrials.gov, the official U.S. registry of clinical studies.
What phases are cancer trials in Germany?
Active cancer trials in Germany span Phase 1, Phase 1, Phase 2. Phase I trials test safety, Phase II test efficacy, and Phase III compare against standard treatments in larger patient populations.